Ahead of monthly derivatives expiry, Sensex hit a lifetime high of 44,825 today, while Nifty touched a record high of 13,145. Yesterday, Sensex ended 445 points higher at 44,523 and Nifty gained 128 points to 13,055

Amid robust liquidity in the market, analysts estimate that the primary market is likely to stay strong and believe that Kalyan Jewellers would be one of the most anticipated IPOs in next one year

Govt has asked RBI to take action against people in management who drives banks to brink of collapse, says Union minister Prakash Javadekar; deal also marks  first instance when a foreign entity was roped in to bail out a struggling bank in India

Despite significant Chinese investment in Paytm, founder Vijay Shekhar Sharma has been vocal about his support for ban on apps from neighbouring country. He was among first ones to laud government's decision to ban 59 Chinese apps back in June

All the three persons were arrested and the gold valuing Rs 72.5 lakh was seized

State laws may delay progress of Centre's agri-marketing reforms, but won't be able to halt them

You can save taxes either by investing in government-notified products or by claiming exemptions on certain type of expenses. The lowdown

Liquidity rush from major central banks has pushed markets into a high valuation zone. Why investors should tread cautiously as India gets into pandemic fatigue

How the 64-year-old Life Insurance Corporation should be valued for stock market listing

The pandemic had put the brakes on the government's ambitious disinvestment plans for the fiscal. However, things have started picking up as businesses go back to normal and markets regain their appetite for buying assets. DIPAM Secretary Tuhin Kanta Pandey lays down the road ahead for the department

In stark contrast to the mayhem around the world, India's top three candidates - Serum-Oxford, Bharat Biotech and Zydus Cadila continued their scientific pursuits unobtrusively (the fourth, DRL-Gamaleya, just started India trials). At least 16 more vaccines are under development at home

The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research

India Stock Market Highlights Today: Global equities were mostly buoyed today encouraged by news on the development of coronavirus vaccines and more assurance for a transition of power in the US to President-elect Joe Biden

OEMs currently have a capex of around Rs 25,000 - 30,000 crore per year in terms of enhancing their capacity for model launches and upgradation of existing models, according to BWA

The lack of well-defined parameters as opposed to an elastic definition could cause hurt India's credibility as an investment destination for foreign technology companies, in a manner akin to how the vague definition of 'public policy' was earlier used to resist enforcement of foreign arbitral awards

Following a meeting with Wipro's management last week, most analysts agreed that the new structure put in place by the company's CEO Theirry Delaporte is a step in the right direction

Oppo X 2021 comes with a rolling display that is normally 6.7 inches in size but when extended becomes 7.4 inches.

The announcement that comes a day after Oxford-Astrazeneca announced a similar level of efficacy for its COVID-19 vaccine allows India to hope for two vaccines to fight the COVID-19 pandemic in the country

The fresh financing will be used to invest aggressively in technology and product innovation and scale new business verticals, says Cars24

Russia's Sputnik V coronavirus vaccine has shown 95% efficacy, according to a second interim analysis of its human clinical trial data